References
- Gold M. S., Redmond D. E., Jr., Kleber H. D. Clonidine in opiate withdrawal. Lancet 1978; 1: 929–930
- Gold M. S., Redmond D. E., Kleber H. D. Clonidine blocks acute opiate withdrawal symptoms. Lancet 1978; 2: 599–602
- Uhde T. W., Redmond D. E., Kleber H. D. Clonidine suppresses the opioid abstinence syndrome without clonidine-withdrawal symptoms: A blind inpatient study. Psychiatry Res. 1980; 2: 37–47
- Washton A. M., et al. Clonidine for opiate detoxification: Outpatient clinical trial. Am. J. Psychiatry 1980; 137: 1121–1122
- Washton A. M., Resnick R. B. Clonidine vs methadone for opiate detoxification: Double blind outpatient trials. Problems of Drug Dependence: NIDA Research Monograph, L. S. Harris. Department of Health and Human Services publication (ADM). 1980; #34, 89–94; 81–1058
- Charney D. S., et al. The clinical use of clonidine in abrupt withdrawal from methadone. Arch. Gen. Psychiatry 1981; 38: 1273–1277
- Jasinski D. R., Johnson R. E., Kocher T. R. Clonidine in morphine withdrawal: Differential effects on signs and symptoms. Arch. Gen. Psychiatry 1985; 42: 1063–1066
- Kleber H. D., et al. Clonidine in outpatient detoxification from methadone maintenance. Arch. Gen. Psychiatry 1985; 42: 391–394
- Wilson B. K., Elms R. R., Thomson C. P. Outpatient vs hospital methadone detoxification: An experimental comparison. Int. J. Addict. 1975; 10(1)13–21
- Silsby H, Tennant F. S. Short-term, ambulatory detoxification of opiate addicts using methadone. Int. J. Addict. 1974; 9(1)167–170
- Dorus W., Senay E. C, Showalter C. V. Short term detoxification with methadone. Ann. N. Y. Acad. Sci. 1981; 362: 203–216
- Riordan C. E., Kleber H. D. Rapid opiate detoxification with clonidine and naloxone. Lancet 1980; 1: 1079–1080
- Charney D. S., et al. Clonidine and naltrexone. Arch. Gen. Psychiatry 1982; 39: 1327–1332
- Martin W. R., et al. Naltrexone, an antagonist for the treatment of heroin dependence. Arch. Gen. Psychiatry 1973; 28: 784–791
- Hamburg M., Tallman J. F. Chronic morphine administration increases the apparent number of alpha-2 adrenergic receptors in rat brain. Nature 1981; 291: 493–495
- Anderson R. J., et al. Clonidine overdose: Report of six cases and review of the literature. Ann. Emergency Med. 1981; 10(2)107–112
- Wang R. I., et al. Rating the presence and severity of opiate dependence. Clin. Pharmacol. Ther. 1974; 16(4)653–658
- Weisen R. L., et al. The safety and value of naloxone as a therapeutic aid. Drug Alcohol Depend. 1977; 2: 123–130
- Wang R. I., et al. Initial methadone dose in treating opiate addiction. Int. J. Addict. 1982; 17(2)357–363
- Hansson L., et al. Blood pressure crisis following withdrawal of clonidine with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am. Heart J. 1975; 85: 605
- Stelzer F. P., et al. Late toxicity of clonidine withdrawal. New Engl. J. Med. 1976; 294: 1182
- Pettinger W. S. Clonidine–A new antihypertensive drug. New Engl. J. Med. 1975; 293: 1179
- Brahen L. S., et al. Naltrexone and cyclazocine. Arch. Gen. Psychiatry 1977; 34: 1181–1184
- Callahan E. J., . Comparison of two naltrexone treatment programs: Naltrexone alone versus naltrexone plus behavior therapy. Narcotic Antagonists: Naltrexone, D. Julius, P. Renault, et al. NIDA Research Monograph. 1976; 163–171; 9
- Resnick R. B., et al. Psychotherapy and Naltrexone in Opioid Dependence. Paper Presented at Committee on Problems of Drug Dependence. 1980
- Kosten T. R., Kleber H. D. Strategies to improve compliance with narcotic antagonists. Am. J. Alcohol Abuse 1984; 10(2)249–266
- Dorus W. Withdrawal from opioid drugs: A review of techniques and outcomes. Drug Dependent Patients, Treatment and Research, R. J. Craig, S. L. Baker. Thomas, Springfield, Illinois 1982; 7–36
- Rotellar J. A. O., et al. Clonidine in thousand-fold overdose. Lancet 1981; 1: 1312
- Judson B. A., et al. The naloxone test for opiate dependence. Clin. Pharmacol. Ther. 1980; 27: 492–501
- Redmond D. E., Jr., Krystal J. H. Multiple mechanisms of withdrawal from opioid drugs. Annu. Rev. Neurosci. 1984; 7: 443–478
- Korf J., Bunney B. S., Aghajanian G. K. Noradrenergic neurons: Morphine inhibition of spontaneous activity. Eur. J. Pharmacol. 1974; 25: 165–169
- Bird S. J., Kuhar M. J. Iontophoretic application of opiates to the locus coeruleus. Brain Res. 1977; 122: 523–533
- Llorens C, et al. Hypersensitivity to noradrenaline in cortex after chronic morphine: Relevance to tolerance and dependence. Nature 1978; 274: 603–605
- Vasquez B. J., Overstreet D. H., Russell R. W. Psychopharmacological evidence for increase in receptor sensitivity following chronic morphine treatment. Psychopharmacologia 1974; 38: 287–302
- Gunne L. M. Noradrenaline and adrenaline in the rat brain during acute and chronic morphine administration and during withdrawal. Nature 1959; 184: 1950–1951
- Crawley J. N., Laverty R. N., Roth R. H. Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal. Eur. J. Pharmacol. 1979; 57: 247–255
- Laverty R., Roth R. H. Clonidine reverses the increased norepinephrine turnover during morphine withdrawal in rats. Brain Res. 1980; 182: 482–485
- Aghajanian G. K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 1978; 276: 186–188
- Cedarbaum J. M., Aghajanian G. K. Catecholamine receptors on locus coeruleus neurons: Pharmacological characterization. Eur. J. Pharmacol. 1977; 44: 375–385
- Lahti R., Collins R. H. Chronic naloxone results in prolonged increase in opiate binding sites in brain. Eur. J. Pharmacol. 1978; 51: 185–186
- Schulz R., Wuster M., Herz A. Supersensitivity to opioids following the chronic blockage of endorphin action by naloxone. Nauvn Schmiedebergs Arch. Pharmacol. 1979; 306: 93–96
- Kosterlitz H. W., Hughes J. Some thoughts on the significance of enkephalin, the endogenous ligand. Life Sci. 1975; 17: 91–96
- Goldstein A., Cox B. M. Opioid peptides (endorphins in pituitary and brain). Psychoneuroenocrinology 1977; 2: 11–16
- Kleber H. D., et al. Nontolerance to the opioid antagonism of naltrexone. Biol. Psychiatry 1985; 20: 66–72
- Sells S. B. Follow-up and treatment outcome. Substance Abuse: Clinical Problems and Perspectives, J. H. Lowinson, P. Ruiz. Williams and Wilkins, Baltimore, Maryland 1981; 783–800